Scientific Publications
Manuscripts
The Chasm Between Cancer Quality Measures and EHR Data Quality
JCO Clinical Cancer Informatics
Schorer et al.
The Friends of Cancer Research real-world data collaboration pilot 2.0: Methodological recommendations from oncology case studies
Clinical Pharmacology & Therapeutics
Rivera et a.
Predicting cardiac adverse events in patients receiving immune checkpoint inhibitors: a machine learning approach
Journal for Immunotherapy of Cancer
Heilbroner et al.
Survival in the real world: A national analysis of patients treated for early-stage breast cancer
JCO Oncology Practice
Gidwani et al.
Summary of the 12 Most Common Cancers in the CancerLinQ Discovery® (CLQD) Database
JCO Clinical Cancer Informatics
Potter et al.
Identification of transgender people with cancer in electronic health records (EHR): Recommendations based on CancerLinQ® observations
JCO Oncology Practice
Alpert et al.
Challenges and Opportunities to Developing a Frailty Index Using Electronic Health Record Data
Journal of Geriatric Oncology
Levit et al.
Impact of Broadening Trial Eligibility Criteria for Advanced Non-Small Cell Lung Cancer (NSCLC) Patients: Real-World Analysis of Select ASCO-Friends R…
Cancer Clinical Research
Harvey et al.
Utilizing Data Visualization to Identify Survival and Treatment Differences Between Women With De Novo and Recurrent Metastatic Breast Cancer
Clinical Breast Cancer
Gilbert et al.
Abstracts
Comparison of DNA sequencing, immunohistochemistry, and in-situ hybridization techniques to determine HER2 status in metastatic breast cancer patients
ASCO 2022 Annual Meeting
Lal LS
Characterizing node-negative non-small cell lung cancer patients with similarity networks: A CancerLinQ Discovery analysis
ASCO 2022 Annual Meeting
Moen EL
Impact of trial site selection on minority patient recruitment in prostate cancer trials
ASCO 2022 Annual Meeting
Lagor C
Natural language processing-optimized case selection for real world evidence studies
ASCO 2022 Annual Meeting
Koskimaki J
Identifying genetic factors of response and resistance to CDK4/6 inhibitors in metastatic HR+/HER2- breast cancer using real-world data
ASCO 2022 Annual Meeting
Agrawal S
Associations between biomarker testing and characteristics of patients with metastatic non-small cell lung cancer (mNSCLC): an analysis of CancerLinQ…
ASCO 2022 Annual Meeting
Mileham KF
Evaluating the impact of performance status criteria on minority eligibility for oncology clinical trials
ASCO 2022 Annual Meeting
Bhandari S
Molecular testing and patterns of treatment in NSCLC patients: An IASLC analysis of ASCO CancerLinQ Discovery data
ASCO 2022 Annual Meeting
Behera M
Machine learning modeling of real-world primary resistance and hyperprogression in immune checkpoint inhibitor (ICI) treated advanced non-small cell l…
ASCO 2022 Annual Meeting
Das R
